NEW YORK, NY / ACCESSWIRE / November 23, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Skullcandy Inc (SKUL), Gold Resource Corp (GORO), McClatchy Co (MNI) and Pluristem Therapeutics Inc (PSTI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

SKUL Research Package: http://www.traders-choice.com/pdf?s=SKUL

GORO Research Package: http://www.traders-choice.com/pdf?s=GORO

MNI Research Package: http://www.traders-choice.com/pdf?s=MNI

PSTI Research Package: http://www.traders-choice.com/pdf?s=PSTI

============

Highlights from today's reports include:

On Friday, November 20, 2015, the NASDAQ Composite ended at 5,104.92, up 0.62%, the Dow Jones Industrial Average advanced 0.51%, to finish the day at 17,823.81, and the S&P 500 closed at 2,089.17, up 0.38%.

- Skullcandy Inc's stock edged higher by 0.94% to close Friday's session at USD 4.31. The company's shares oscillated between USD 4.30 and USD 4.42. The stock recorded a trading volume of 0.25 million shares, which was above its 50-day daily average volume of 0.22 million shares and below its 52-week average volume of 0.27 million shares. Over the last three days, Skullcandy Inc's shares have advanced 1.17% and in the past one week it has moved up 0.47%. However, over the last three months, the stock has lost 37.81% and in the past six months, the shares have shed 46.79%. Further, the company is trading at a price to earnings ratio of 17.24 and a price to book ratio of 0.78. This compares to a historical PE ratio of 34.55. The historical PB ratio is near to 1.70. Additionally, the stock is trading at a price to cash flow ratio of 4.62 and price to sales ratio of 0.45.

- The stock of Gold Resource Corp lost 5.08% to close Friday's session at USD 2.24. The shares of the company moved in the range of USD 2.21 and USD 2.40. A trading volume of 0.20 million shares was recorded, which was lower than its 150-day daily average volume of 0.45 million shares and below its 52-week average volume of 0.50 million shares. Over the last five days, Gold Resource Corp's shares have declined by 0.88% and in the past one month, it has lost 18.84%. Gold Resource Corp has a current dividend yield of 5.36%. Further, the company is trading at a price to earnings ratio of 14.93 and a price to book ratio of 1.36. This compares to a historical PE ratio of 11.36. The historical PB ratio is near to 2.03. Further, the stock is trading at a price to cash flow ratio of 5.02 and price to sales ratio of 1.29.

- McClatchy Co's stock increased by 1.44% to close Friday's session at USD 1.41. The company's shares fluctuated in the range of USD 1.36 and USD 1.44. A total of 0.17 million shares exchanged hands, which was lesser than its 50-day daily average volume of 0.26 million shares and was below its 52-week average volume of 0.38 million shares. Over the last three days McClatchy Co's shares have advanced 2.17% and in the past one week it has moved up 0.71%. Furthermore, over the last three months, the stock has gained 53.26% and in the past six months, the shares have picked up 18.49%. The company has returned 46.11% in the past three months, and 11.02% in the last half year, on a compounded total return basis. The stock is at a price to book ratio of 0.59. The historical PB ratio is near to 0.60. Additionally, the stock is trading at a price to sales ratio of 0.08.

- Pluristem Therapeutics Inc's stock added 1.00% to close Friday's session at USD 1.52. The company's shares oscillated between USD 1.48 and USD 1.53. The stock recorded a trading volume of 0.07 million shares, which was below its 50-day daily average volume of 0.10 million shares and lower than its 52-week average volume of 0.18 million shares. The stock is trading below its 50-day and 200-day moving average of USD 1.68 and USD 2.20, respectively. Over the last five days, Pluristem Therapeutics Inc's shares have declined by 0.98% and in the past one month, it has lost 11.92%. The stock is at a price to book ratio of 2.27. The historical PB ratio is near to 3.41. Additionally, the stock is trading at a price to sales ratio of 313.92. The bio-therapeutics company has a market cap of USD 120.16 million.

--

About Trader's Choice:

Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

E-mail: press (at) traders-choice.com

SOURCE: Trader's Choice